Richard Pazdur Appointed Director of the FDA’s Drug Center: A New Chapter for Cancer Regulation

oncodaily - Dr. Richard Pazdur, one of the most influential figures in oncology drug regulation, has been appointed Director of the U.S. Food and Drug Administration’s (FDA) Center for Drug Evaluation and […]

AI Summary: The FDA has ushered in a new era in oncology drug oversight by appointing Dr. Richard Pazdur as the director of its Drug Center. The move comes amid agency challenges and staff cuts, promising stabilizing leadership at one of its most influential divisions.

---

Warning: Undefined variable $thumbnail in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 61

Related Stories

---

Warning: Undefined variable $top_stories in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 128

FDA commissioner Marty Makary resigns amid mounting scrutiny / 19 days

FDA Abortion Pill Decisions Rooted in Science / 4 months

FDA loosens data restrictions to accelerate drug reviews / 5 months

FDA links eight deaths to Amgen’s Tavneos; scrutiny intensifies / 1 month

FDA approves leucovorin for rare folate disorder despite autism hype / 2 months

FDA launches individualized therapy framework for ultra-rare diseases / 3 months

FDA makes one pivotal trial the default for drug approvals / 3 months